首页 > 最新文献

Vestnik oftalmologii最新文献

英文 中文
[Changes in the precorneal tear film at various stages of keratoconus]. [角膜病不同阶段角膜前泪膜的变化]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414003143
V V Averich, I A Bubnova

The combination of keratoconus (KC) with signs of dry eye disease (DES) has been described in numerous scientific publications. At the same time, there is a relationship between KC stage and an increase in the severity of DES symptoms, however, there is still no common understanding of the severity of xerotic process depending on the clinical course of keratectasia.

Purpose: This study assesses the changes in the state of the precorneal tear film in KC relative to the stages of the disease.

Material and methods: The study included 50 patients (100 eyes) with bilateral non-operated KC from subclinical to stage IV. The following methods were used for a comprehensive assessment of the condition of the tear film: biomicroscopy of the anterior segment of the eye using vital dyes, functional tests (Norn, Schirmer, Jones tests), tearscopy of the lipid layer of the tear film with software processing of the results, OCT-meniscometry, as well as filling out the OSDI questionnaire by patients.

Results: The following significant changes were revealed as the KC stage progressed: an increase in the area of staining of the ocular surface with vital dyes, a decrease in the results of the Norn functional test and OCT-meniscometry, an increase in the areas of smaller thickness of lipids and areas of their complete absence according to tearscopy, as well as an increase in scores of the OSDI questionnaire.

Conclusion: A comprehensive assessment of the condition of the tear film in KC indicates the relationship and the strengthening of the signs of DES as keratectasia progresses, and can be considered as justification for the need to prescribe tear replacement and reparative therapy that improves the condition of the ocular surface and stabilizes the precorneal tear film.

许多科学出版物都描述了角膜炎(KC)与干眼症(DES)症状的结合。目的:本研究评估了 KC 角膜前泪膜状态相对于疾病阶段的变化:研究对象包括 50 名双侧非手术 KC 患者(100 只眼),从亚临床期到 IV 期。采用以下方法对泪膜状况进行综合评估:使用重要染料对眼球前段进行生物显微镜检查、功能测试(Norn、Schirmer、Jones 测试)、对泪膜脂质层进行泪液检查并对结果进行软件处理、OCT-验光法以及由患者填写 OSDI 问卷:结果:随着 KC 阶段的进展,出现了以下明显变化:眼表被重要染料染色的面积增加,Norn 功能测试和 OCT-验光结果减少,泪液镜检查显示脂质厚度较小的区域和完全没有脂质的区域增加,以及 OSDI 问卷得分增加:结论:对 KC 泪膜状况的全面评估表明,随着角膜营养不良的发展,DES 征兆与角膜营养不良之间存在着联系并不断加强,因此有必要采取泪液替代和修复疗法,以改善眼表状况并稳定角膜前泪膜。
{"title":"[Changes in the precorneal tear film at various stages of keratoconus].","authors":"V V Averich, I A Bubnova","doi":"10.17116/oftalma202414003143","DOIUrl":"https://doi.org/10.17116/oftalma202414003143","url":null,"abstract":"<p><p>The combination of keratoconus (KC) with signs of dry eye disease (DES) has been described in numerous scientific publications. At the same time, there is a relationship between KC stage and an increase in the severity of DES symptoms, however, there is still no common understanding of the severity of xerotic process depending on the clinical course of keratectasia.</p><p><strong>Purpose: </strong>This study assesses the changes in the state of the precorneal tear film in KC relative to the stages of the disease.</p><p><strong>Material and methods: </strong>The study included 50 patients (100 eyes) with bilateral non-operated KC from subclinical to stage IV. The following methods were used for a comprehensive assessment of the condition of the tear film: biomicroscopy of the anterior segment of the eye using vital dyes, functional tests (Norn, Schirmer, Jones tests), tearscopy of the lipid layer of the tear film with software processing of the results, OCT-meniscometry, as well as filling out the OSDI questionnaire by patients.</p><p><strong>Results: </strong>The following significant changes were revealed as the KC stage progressed: an increase in the area of staining of the ocular surface with vital dyes, a decrease in the results of the Norn functional test and OCT-meniscometry, an increase in the areas of smaller thickness of lipids and areas of their complete absence according to tearscopy, as well as an increase in scores of the OSDI questionnaire.</p><p><strong>Conclusion: </strong>A comprehensive assessment of the condition of the tear film in KC indicates the relationship and the strengthening of the signs of DES as keratectasia progresses, and can be considered as justification for the need to prescribe tear replacement and reparative therapy that improves the condition of the ocular surface and stabilizes the precorneal tear film.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"43-49"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol) in primary open-angle glaucoma]. [多佐胺/噻吗洛尔固定组合(多佐替莫尔)对原发性开角型青光眼的疗效和安全性]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma2024140051125
E V Karlova, E B Eroshevskaya

Safe and effective glaucoma treatment remains a critical task in ophthalmology. Newly introduced medications, in addition to mandatory registration trials, are also evaluated in real-world clinical settings.

Purpose: This study assesses the efficacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol) in patients with primary open-angle glaucoma (POAG) in real-world clinical settings.

Material and methods: The study included 55 patients aged 46 to 75 years with stage I and II POAG. The initial mean intraocular pressure (IOP) was 24.07±1.31 mm Hg. All patients were prescribed the fixed combination of dorzolamide/timolol.

Results: The mean IOP after 1, 3, 6, and 12 weeks of therapy was 19.20±2.46, 18.48±2.04, 17.88±1.88, and 17.62±1.63 mm Hg, respectively. After 12 weeks of therapy, IOP reduction to 18 mm Hg was observed in 63.64% of patients, a reduction of 20% or more from baseline in 81.82% of patients, and a reduction of 30% or more in 14.55% of patients. No serious adverse events were recorded during the observation period.

Conclusion: This study confirms the high hypotensive efficacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol).

安全有效地治疗青光眼仍然是眼科领域的一项重要任务。目的:本研究评估了原发性开角型青光眼(POAG)患者在实际临床环境中使用多佐胺/噻吗洛尔(Dorzotimol)固定联合用药的疗效和安全性:研究纳入了 55 名年龄在 46 岁至 75 岁之间的 I 期和 II 期 POAG 患者。初始平均眼压(IOP)为 24.07±1.31 mm Hg。所有患者均处方多佐胺/噻吗洛尔固定组合:治疗 1、3、6 和 12 周后的平均眼压分别为(19.20±2.46)、(18.48±2.04)、(17.88±1.88)和(17.62±1.63)毫米汞柱。治疗 12 周后,63.64% 的患者眼压降至 18 毫米汞柱,81.82% 的患者眼压比基线降低 20% 或更多,14.55% 的患者眼压降低 30% 或更多。观察期间未出现严重不良反应:这项研究证实了多佐胺/噻吗洛尔固定联合用药(多佐替莫尔)具有很高的降压疗效和安全性。
{"title":"[Efficacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol) in primary open-angle glaucoma].","authors":"E V Karlova, E B Eroshevskaya","doi":"10.17116/oftalma2024140051125","DOIUrl":"https://doi.org/10.17116/oftalma2024140051125","url":null,"abstract":"<p><p>Safe and effective glaucoma treatment remains a critical task in ophthalmology. Newly introduced medications, in addition to mandatory registration trials, are also evaluated in real-world clinical settings.</p><p><strong>Purpose: </strong>This study assesses the efficacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol) in patients with primary open-angle glaucoma (POAG) in real-world clinical settings.</p><p><strong>Material and methods: </strong>The study included 55 patients aged 46 to 75 years with stage I and II POAG. The initial mean intraocular pressure (IOP) was 24.07±1.31 mm Hg. All patients were prescribed the fixed combination of dorzolamide/timolol.</p><p><strong>Results: </strong>The mean IOP after 1, 3, 6, and 12 weeks of therapy was 19.20±2.46, 18.48±2.04, 17.88±1.88, and 17.62±1.63 mm Hg, respectively. After 12 weeks of therapy, IOP reduction to 18 mm Hg was observed in 63.64% of patients, a reduction of 20% or more from baseline in 81.82% of patients, and a reduction of 30% or more in 14.55% of patients. No serious adverse events were recorded during the observation period.</p><p><strong>Conclusion: </strong>This study confirms the high hypotensive efficacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol).</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 5","pages":"125-129"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Early changes in choroidal thickness and axial length in the use glasses of monofocal lenses and highly aspherical lenslets in children with newly diagnosed myopia]. [新诊断近视的儿童在使用单焦镜片和高非球面镜片眼镜时脉络膜厚度和轴长的早期变化]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414005118
E P Tarutta, S E Kondratova, S V Milash

Current strategies for treating progressive myopia are closely linked to optical methods based on the theory of peripheral defocus. Myopic defocus causes an increase in choroidal thickness (CT) and a decrease in axial length (AL) of the eye. No comparative studies on the effects of spectacle lenses with highly aspherical lenslets (HAL) and monofocal lenses (MFL) on CT and AL in children with newly diagnosed myopia have been conducted.

Purpose: This study compares changes in CT and AL in children with myopia after one month of continuous wear of newly prescribed glasses with HAL and MFL.

Material and methods: The study included a total of 29 patients (58 eyes) with newly diagnosed mild myopia (mean -1.28±0.64 D) at an average age of 10.41±1.14 years wearing newly prescribed glasses with MFL (group 1) or with HAL (group 2). All patients underwent optical biometry and CT measurement using optical coherence tomography in addition to standard ophthalmological examination methods.

Results: In group 1 (SV), subfoveal CT decreased significantly by 18.13±7.88 μm after 1 month, while in group 2 (HAL), it increased by 12.88±29.86 μm. AL significantly increased by an average of 0.04±0.04 mm in group 1 and decreased by an average of 0.06±0.07 mm in group 2 (p<0.05).

Conclusions: The use of optical means of correction leads to changes in biometric parameters of the eye within a month from the start of wearing them. A decrease in CT from baseline was observed with MFL glasses, while an increase was seen with HAL correction, which can be considered a favorable prognostic sign in the control of progressive myopia in children.

目前治疗渐进性近视的策略与基于周边散焦理论的光学方法密切相关。近视散焦会导致脉络膜厚度(CT)增加和眼轴长度(AL)减少。目前还没有关于高非球面镜片(HAL)和单焦点镜片(MFL)对新诊断为近视的儿童的 CT 和 AL 的影响的比较研究。目的:本研究比较了近视儿童在连续佩戴一个月新处方的 HAL 和 MFL 眼镜后 CT 和 AL 的变化:本研究共纳入 29 名新确诊的轻度近视患者(58 只眼),平均年龄(10.41±1.14)岁,佩戴新处方的 MFL(第 1 组)或 HAL(第 2 组)眼镜。除了标准的眼科检查方法外,所有患者都接受了光学生物测量和光学相干断层扫描测量:结果:在第 1 组(SV)中,1 个月后眼底 CT 明显下降了 18.13±7.88 μm,而在第 2 组(HAL)中,眼底 CT 上升了 12.88±29.86 μm。第 1 组的 AL 平均明显增加了(0.04±0.04)毫米,而第 2 组平均减少了(0.06±0.07)毫米(p 结论:使用光学矫正方法会在开始佩戴后一个月内导致眼部生物计量参数发生变化。MFL眼镜的CT值较基线值有所下降,而HAL矫正眼镜的CT值较基线值有所上升。
{"title":"[Early changes in choroidal thickness and axial length in the use glasses of monofocal lenses and highly aspherical lenslets in children with newly diagnosed myopia].","authors":"E P Tarutta, S E Kondratova, S V Milash","doi":"10.17116/oftalma202414005118","DOIUrl":"https://doi.org/10.17116/oftalma202414005118","url":null,"abstract":"<p><p>Current strategies for treating progressive myopia are closely linked to optical methods based on the theory of peripheral defocus. Myopic defocus causes an increase in choroidal thickness (CT) and a decrease in axial length (AL) of the eye. No comparative studies on the effects of spectacle lenses with highly aspherical lenslets (HAL) and monofocal lenses (MFL) on CT and AL in children with newly diagnosed myopia have been conducted.</p><p><strong>Purpose: </strong>This study compares changes in CT and AL in children with myopia after one month of continuous wear of newly prescribed glasses with HAL and MFL.</p><p><strong>Material and methods: </strong>The study included a total of 29 patients (58 eyes) with newly diagnosed mild myopia (mean -1.28±0.64 D) at an average age of 10.41±1.14 years wearing newly prescribed glasses with MFL (group 1) or with HAL (group 2). All patients underwent optical biometry and CT measurement using optical coherence tomography in addition to standard ophthalmological examination methods.</p><p><strong>Results: </strong>In group 1 (SV), subfoveal CT decreased significantly by 18.13±7.88 μm after 1 month, while in group 2 (HAL), it increased by 12.88±29.86 μm. AL significantly increased by an average of 0.04±0.04 mm in group 1 and decreased by an average of 0.06±0.07 mm in group 2 (<i>p</i><0.05).</p><p><strong>Conclusions: </strong>The use of optical means of correction leads to changes in biometric parameters of the eye within a month from the start of wearing them. A decrease in CT from baseline was observed with MFL glasses, while an increase was seen with HAL correction, which can be considered a favorable prognostic sign in the control of progressive myopia in children.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 5","pages":"18-24"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical outcomes of SMILE Xtra for myopia correction]. [SMILE Xtra 用于近视矫正的临床结果]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414005187
A A Kozhukhov, O V Unguryanov, T L Fadeikina, M V Zimina, O A Chukanin

Purpose: This study assesses the treatment outcomes of patients with thin corneas and/or borderline corneal topography who underwent combined refractive surgery using the SMILE Xtra technique.

Material and methods: The study included 53 patients (105 eyes) with myopia and a risk of developing keratectasia according to the Randleman criteria. All patients underwent prophylactic crosslinking following the SMILE procedure by introducing riboflavin solution into the corneal pocket, followed by ultraviolet irradiation according to the SUB-400 protocol with additional acceleration. The results were evaluated using data from Scheimpflug analyzer, analysis of corneal biomechanical properties, optical coherence tomography (OCT), and standard ophthalmological examinations. Follow-up lasted up to 12 months.

Results: The preoperative spherical equivalent of refraction was -4.09±1.30 D, and postoperative measurements on day 1, day 7, and at 1, 3, 6, and 12 months were: -0.08±0.64; 0.1±0.53; 0.2±0.48; 0.05±0.52; -0.29±0.47; 0.1±0.49 D, respectively. On day 1, uncorrected visual acuity (UCVA) increased to 0.78±0.17, rising to 0.94±0.11 by day 7, and remained stable throughout the follow-up. Mean keratometry values preoperatively were 44.32±1.3 D, and 40.89±1.65 D on day 1, with no statistically significant changes throughout the follow-up. Central corneal thickness decreased from 528.30±28.71 μm preoperatively to 459.32±28.92 μm on day 1 and 440.54±29.12 μm on day 7. Patient complaints of blurred vision on day 1 were associated with mild corneal edema due to residual riboflavin and energy load from UV treatment; these symptoms resolved by day 7. No regression of refractive results or keratectasia was observed throughout the follow-up period.

Conclusion: SMILE Xtra can be used for myopia correction in cases with an increased risk of postoperative keratectasia in patients with thin corneas and/or borderline corneal topography readings.

目的:本研究评估了使用SMILE Xtra技术对角膜薄和/或角膜地形图边缘的患者进行联合屈光手术的治疗效果:研究对象包括53名近视患者(105只眼),根据兰德尔曼标准,这些患者有患角膜营养不良的风险。所有患者在 SMILE 手术后都接受了预防性交联,将核黄素溶液导入角膜袋,然后按照 SUB-400 方案进行紫外线照射,并增加了加速度。结果通过Scheimpflug分析仪的数据、角膜生物力学特性分析、光学相干断层扫描(OCT)和标准眼科检查进行评估。随访时间长达 12 个月:结果:术前屈光球面等效度数为-4.09±1.30 D,术后第1天、第7天以及1、3、6和12个月的测量值分别为-0.08±0.64 D、-0.08±0.64 D、-0.08±0.64 D和-0.08±0.64 D:术后第 1 天、第 7 天、1、3、6 和 12 个月的测量值分别为:-0.08±0.64;0.1±0.53;0.2±0.48;0.05±0.52;-0.29±0.47;0.1±0.49 D。第1天,未矫正视力(UCVA)增至0.78±0.17,第7天增至0.94±0.11,并在整个随访期间保持稳定。术前的平均角膜度数值为 44.32±1.3D,第 1 天为 40.89±1.65D,整个随访期间无明显统计学变化。中心角膜厚度从术前的 528.30±28.71 μm 降至第 1 天的 459.32±28.92 μm,第 7 天降至 440.54±29.12 μm。患者在第 1 天抱怨视力模糊,这与紫外线治疗中残留的核黄素和能量负荷导致的轻度角膜水肿有关;这些症状在第 7 天得到缓解。在整个随访期间,没有观察到屈光结果或角膜软化症的消退:结论:SMILE Xtra 可用于近视矫正,但角膜较薄和/或角膜地形图读数较边缘的患者术后发生角膜病变的风险较高。
{"title":"[Clinical outcomes of SMILE Xtra for myopia correction].","authors":"A A Kozhukhov, O V Unguryanov, T L Fadeikina, M V Zimina, O A Chukanin","doi":"10.17116/oftalma202414005187","DOIUrl":"https://doi.org/10.17116/oftalma202414005187","url":null,"abstract":"<p><strong>Purpose: </strong>This study assesses the treatment outcomes of patients with thin corneas and/or borderline corneal topography who underwent combined refractive surgery using the SMILE Xtra technique.</p><p><strong>Material and methods: </strong>The study included 53 patients (105 eyes) with myopia and a risk of developing keratectasia according to the Randleman criteria. All patients underwent prophylactic crosslinking following the SMILE procedure by introducing riboflavin solution into the corneal pocket, followed by ultraviolet irradiation according to the SUB-400 protocol with additional acceleration. The results were evaluated using data from Scheimpflug analyzer, analysis of corneal biomechanical properties, optical coherence tomography (OCT), and standard ophthalmological examinations. Follow-up lasted up to 12 months.</p><p><strong>Results: </strong>The preoperative spherical equivalent of refraction was -4.09±1.30 D, and postoperative measurements on day 1, day 7, and at 1, 3, 6, and 12 months were: -0.08±0.64; 0.1±0.53; 0.2±0.48; 0.05±0.52; -0.29±0.47; 0.1±0.49 D, respectively. On day 1, uncorrected visual acuity (UCVA) increased to 0.78±0.17, rising to 0.94±0.11 by day 7, and remained stable throughout the follow-up. Mean keratometry values preoperatively were 44.32±1.3 D, and 40.89±1.65 D on day 1, with no statistically significant changes throughout the follow-up. Central corneal thickness decreased from 528.30±28.71 μm preoperatively to 459.32±28.92 μm on day 1 and 440.54±29.12 μm on day 7. Patient complaints of blurred vision on day 1 were associated with mild corneal edema due to residual riboflavin and energy load from UV treatment; these symptoms resolved by day 7. No regression of refractive results or keratectasia was observed throughout the follow-up period.</p><p><strong>Conclusion: </strong>SMILE Xtra can be used for myopia correction in cases with an increased risk of postoperative keratectasia in patients with thin corneas and/or borderline corneal topography readings.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 5","pages":"87-96"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Perioperative prevention of bleeding in glaucoma surgery]. [青光眼手术出血的围手术期预防]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma2024140051118
A A Antonov, A A Vitkov, A V Volzhanin, I V Kozlova, S A Ovsepyan

Purpose: This study assesses the impact of preoperative administration of Oku-Oku eye drops on the severity of conjunctival hyperemia and the risk of hemorrhagic complications in the early postoperative period following glaucoma surgery.

Material and methods: The study included a group of 30 patients (30 eyes) with uncontrolled primary open-angle glaucoma who underwent non-penetrating deep sclerectomy. The main group included 15 eyes, in which Oku-Oku drops were administered twice - on the day before surgery (upon hospital admission) and immediately before the operation. The control group consisted of 15 eyes that underwent surgery without additional medications. Intraocular pressure (IOP) and conjunctival hyperemia were measured before and after surgery. The duration of coagulation during surgery was also recorded. The rate of hemorrhagic complications was compared between the groups.

Results: The performed glaucoma surgery significantly reduced IOP in both groups, with no significant differences in postoperative IOP levels. Conjunctival hyperemia increased in both groups postoperatively, though the increase was slightly less in the main group. There was a significant difference in the duration of scleral vessel coagulation in the surgical area, amounting to 3.8±2.6 seconds in the main group and 6.9±3.0 seconds in the control group. Hemorrhagic complications occurred less frequently in the main group.

Conclusion: Preoperative use of Oku-Oku eye drops reduced the severity of conjunctival hyperemia and the width of scleral vessels. The reduction in hemorrhagic complications in the early postoperative period may contribute to decreased scarring. Oku-Oku can be included in the comprehensive preoperative preparation for glaucoma surgery and other procedures with a risk of bleeding. Further research is needed to evaluate the effectiveness of Oku-Oku in the perioperative period.

目的:本研究评估了术前使用奥光学滴眼液对结膜充血严重程度以及青光眼手术后早期出血并发症风险的影响:研究对象为接受非穿透性深巩膜切除术的未控制原发性开角型青光眼患者(30 眼)。主要组包括 15 只眼睛,在手术前一天(入院时)和手术前立即滴用两次奥光学滴眼液。对照组包括15只眼睛,他们在没有额外用药的情况下接受了手术。手术前后测量了眼压和结膜充血情况。同时还记录了手术过程中凝血时间的长短。两组患者的出血并发症发生率进行了比较:结果:两组接受青光眼手术后的眼压均明显下降,术后眼压水平无明显差异。两组患者术后结膜充血程度均有所上升,但主要组患者的上升程度略低。手术区巩膜血管凝固的持续时间有明显差异,主要组为 3.8±2.6 秒,对照组为 6.9±3.0 秒。结论:结论:术前使用奥光学眼药水可降低结膜充血的严重程度和巩膜血管的宽度。术后早期出血并发症的减少可能是瘢痕形成减少的原因之一。奥光学可用于青光眼手术和其他有出血风险的手术的全面术前准备。要评估奥光学在围手术期的效果,还需要进一步的研究。
{"title":"[Perioperative prevention of bleeding in glaucoma surgery].","authors":"A A Antonov, A A Vitkov, A V Volzhanin, I V Kozlova, S A Ovsepyan","doi":"10.17116/oftalma2024140051118","DOIUrl":"https://doi.org/10.17116/oftalma2024140051118","url":null,"abstract":"<p><strong>Purpose: </strong>This study assesses the impact of preoperative administration of Oku-Oku eye drops on the severity of conjunctival hyperemia and the risk of hemorrhagic complications in the early postoperative period following glaucoma surgery.</p><p><strong>Material and methods: </strong>The study included a group of 30 patients (30 eyes) with uncontrolled primary open-angle glaucoma who underwent non-penetrating deep sclerectomy. The main group included 15 eyes, in which Oku-Oku drops were administered twice - on the day before surgery (upon hospital admission) and immediately before the operation. The control group consisted of 15 eyes that underwent surgery without additional medications. Intraocular pressure (IOP) and conjunctival hyperemia were measured before and after surgery. The duration of coagulation during surgery was also recorded. The rate of hemorrhagic complications was compared between the groups.</p><p><strong>Results: </strong>The performed glaucoma surgery significantly reduced IOP in both groups, with no significant differences in postoperative IOP levels. Conjunctival hyperemia increased in both groups postoperatively, though the increase was slightly less in the main group. There was a significant difference in the duration of scleral vessel coagulation in the surgical area, amounting to 3.8±2.6 seconds in the main group and 6.9±3.0 seconds in the control group. Hemorrhagic complications occurred less frequently in the main group.</p><p><strong>Conclusion: </strong>Preoperative use of Oku-Oku eye drops reduced the severity of conjunctival hyperemia and the width of scleral vessels. The reduction in hemorrhagic complications in the early postoperative period may contribute to decreased scarring. Oku-Oku can be included in the comprehensive preoperative preparation for glaucoma surgery and other procedures with a risk of bleeding. Further research is needed to evaluate the effectiveness of Oku-Oku in the perioperative period.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 5","pages":"118-124"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Spontaneous rupture of the anterior lens capsule in Alport syndrome (case study)]. [阿尔波特综合征的晶状体前囊自发性破裂(病例研究)]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414003176
E N Batkov, V I Mikhaylova

Alport syndrome is a hereditary disease characterized by glomerulopathy, manifested by hematuria and/or proteinuria, progressive decline in renal function, often combined with hearing and vision pathology. This article presents a clinical case of spontaneous opening of the anterior lens capsule in a patient with Alport syndrome, accompanied by uveitis and ophthalmic hypertension, and describes the features of the surgical aid and the postoperative period.

阿尔波特综合征是一种以肾小球病变为特征的遗传性疾病,表现为血尿和/或蛋白尿,肾功能进行性下降,常合并听力和视力病变。本文介绍了一例阿尔波特综合征患者晶状体前囊自发性裂开并伴有葡萄膜炎和眼压升高的临床病例,并介绍了手术辅助和术后的特点。
{"title":"[Spontaneous rupture of the anterior lens capsule in Alport syndrome (case study)].","authors":"E N Batkov, V I Mikhaylova","doi":"10.17116/oftalma202414003176","DOIUrl":"10.17116/oftalma202414003176","url":null,"abstract":"<p><p>Alport syndrome is a hereditary disease characterized by glomerulopathy, manifested by hematuria and/or proteinuria, progressive decline in renal function, often combined with hearing and vision pathology. This article presents a clinical case of spontaneous opening of the anterior lens capsule in a patient with Alport syndrome, accompanied by uveitis and ophthalmic hypertension, and describes the features of the surgical aid and the postoperative period.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"76-81"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transscleral fixation of intraocular lens in the treatment of lens subluxation in children]. [经巩膜固定眼内晶状体治疗儿童晶状体脱位]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414003127
L N Orazbekov, A A Shabanova

Congenital subluxation of the lens as a complication of Marfan syndrome, Weill-Marchesani syndrome, microspherophakia, etc. leads to the development of amblyopia and requires timely surgical treatment with removal of the subluxated lens and implantation of an artificial intraocular lens (IOL). IOL implantation in children with pathology of the ligamentous apparatus of the lens remains an urgent problem of ophthalmic surgery due to the lack of a consensus regarding the IOL fixation method among practitioners.

Purpose: This study evaluated the effectiveness and safety of IOL implantation with transscleral fixation using the knotless Z-suture technique in pediatric patients with congenital lens subluxation.

Material and methods: The study included 24 children (36 eyes) with grade III congenital subluxation of the lens who underwent phacoaspiration of the subluxated lens with IOL implantation with transscleral fixation using the knotless Z-suture performed in the Kazakh Research Institute of Eye Diseases in Almaty in the period from 2017 to 2021. The average observation period was 31.7±11.3 months (2.0 to 4.5 years). The stability of the IOL position, the state of the intrascleral sutures, visual acuity after surgery, the presence and severity of complications in the long-term period were evaluated.

Results: All patients (100%) had a significant improvement in visual acuity after surgery. No intraoperative complications were registered in any of the cases. Postoperative complications were noted in 8.3% of cases (n=3). The final functional outcome of surgical treatment depended on the presence of concomitant pathology, the main cause of low vision was the development of refractive amblyopia due to refractive errors.

Conclusions: The presented technique of transscleral fixation of IOL has proven to be reliable, which is especially important for pediatric patients considering their high physical activity and expected lifespan.

先天性晶状体半脱位是马凡氏综合征、Weill-Marchesani 综合征、小球海绵体视网膜炎等疾病的并发症,会导致弱视的发生,需要及时进行手术治疗,摘除半脱位的晶状体并植入人工晶状体(IOL)。目的:本研究评估了在先天性晶状体脱位的儿童患者中使用无结 Z 形缝线技术经巩膜固定植入人工晶体的有效性和安全性:研究纳入了2017年至2021年期间在阿拉木图哈萨克眼病研究所接受超声乳化吸除先天性晶状体脱位并使用无结Z型缝线经巩膜固定植入人工晶体手术的24名III度先天性晶状体脱位患儿(36眼)。平均观察时间为 31.7±11.3 个月(2.0 至 4.5 年)。对人工晶体位置的稳定性、巩膜内缝合状态、术后视力、长期并发症的出现和严重程度进行了评估:所有患者(100%)术后视力均有明显改善。所有病例均未出现术中并发症。术后出现并发症的病例占 8.3%(3 例)。手术治疗的最终功能结果取决于是否存在并发病症,低视力的主要原因是屈光不正导致的屈光性弱视:所介绍的经巩膜固定人工晶体的技术已被证明是可靠的,考虑到儿童患者的高运动量和预期寿命,这一点对他们尤为重要。
{"title":"[Transscleral fixation of intraocular lens in the treatment of lens subluxation in children].","authors":"L N Orazbekov, A A Shabanova","doi":"10.17116/oftalma202414003127","DOIUrl":"https://doi.org/10.17116/oftalma202414003127","url":null,"abstract":"<p><p>Congenital subluxation of the lens as a complication of Marfan syndrome, Weill-Marchesani syndrome, microspherophakia, etc. leads to the development of amblyopia and requires timely surgical treatment with removal of the subluxated lens and implantation of an artificial intraocular lens (IOL). IOL implantation in children with pathology of the ligamentous apparatus of the lens remains an urgent problem of ophthalmic surgery due to the lack of a consensus regarding the IOL fixation method among practitioners.</p><p><strong>Purpose: </strong>This study evaluated the effectiveness and safety of IOL implantation with transscleral fixation using the knotless Z-suture technique in pediatric patients with congenital lens subluxation.</p><p><strong>Material and methods: </strong>The study included 24 children (36 eyes) with grade III congenital subluxation of the lens who underwent phacoaspiration of the subluxated lens with IOL implantation with transscleral fixation using the knotless Z-suture performed in the Kazakh Research Institute of Eye Diseases in Almaty in the period from 2017 to 2021. The average observation period was 31.7±11.3 months (2.0 to 4.5 years). The stability of the IOL position, the state of the intrascleral sutures, visual acuity after surgery, the presence and severity of complications in the long-term period were evaluated.</p><p><strong>Results: </strong>All patients (100%) had a significant improvement in visual acuity after surgery. No intraoperative complications were registered in any of the cases. Postoperative complications were noted in 8.3% of cases (<i>n</i>=3). The final functional outcome of surgical treatment depended on the presence of concomitant pathology, the main cause of low vision was the development of refractive amblyopia due to refractive errors.</p><p><strong>Conclusions: </strong>The presented technique of transscleral fixation of IOL has proven to be reliable, which is especially important for pediatric patients considering their high physical activity and expected lifespan.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"27-33"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The association between myopia and glaucoma]. [近视与青光眼之间的关联]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma202414001193
A E Aprelev, E O Sukmanyuk, A M Medunitsyna

Myopia and glaucoma are the leading causes of irreversible blindness in the world, and as the number of nearsighted people is predicted to increase sharply in the upcoming decades, an increase in combined pathology is expected. This article analyzes literature sources to assess the epidemiology of glaucoma and myopia both worldwide and in the Russian Federation, examine the anatomical changes of the eyeball associated with these diseases, and identify the diagnostic criteria that facilitate the verification of glaucoma when combined with myopia.

近视和青光眼是世界上导致不可逆失明的主要原因,由于近视人数预计将在未来几十年内急剧增加,预计合并病症也会增加。本文通过分析文献资料,评估了青光眼和近视在全球和俄罗斯联邦的流行病学,研究了与这些疾病相关的眼球解剖学变化,并确定了有助于确诊青光眼合并近视的诊断标准。
{"title":"[The association between myopia and glaucoma].","authors":"A E Aprelev, E O Sukmanyuk, A M Medunitsyna","doi":"10.17116/oftalma202414001193","DOIUrl":"10.17116/oftalma202414001193","url":null,"abstract":"<p><p>Myopia and glaucoma are the leading causes of irreversible blindness in the world, and as the number of nearsighted people is predicted to increase sharply in the upcoming decades, an increase in combined pathology is expected. This article analyzes literature sources to assess the epidemiology of glaucoma and myopia both worldwide and in the Russian Federation, examine the anatomical changes of the eyeball associated with these diseases, and identify the diagnostic criteria that facilitate the verification of glaucoma when combined with myopia.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"93-98"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Structural and functional features of the eye in Marfan syndrome. Report 1. Changes in the fibrous tunic of the eye]. [马凡氏综合征眼球的结构和功能特征。报告 1.眼球纤维膜的变化]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma20241400115
K S Avetisov, E A Chizhonkova, S E Avetisov

Marfan syndrome (MS) is an orphan hereditary connective tissue disease associated with a mutation in the FBN1 gene, which pathological manifestations are characterized by polysystemic involvement. The fibrillin-1 protein is an integral component of the sclera and cornea of the eye, and in MS its structure is distrubed.

Purpose: This study assesses potential structural and functional changes in the cornea and sclera of a patient with MS.

Material and methods: Two groups were formed, comparable in the axial length of the eye and age: the main group - 19 patients (38 eyes) with a verified diagnosis of MS, and the control group - 24 patients (48 eyes) with myopia of varying degrees. The results obtained from MS patients were analyzed depending on the absence or presence of ectopia lentis. In addition to measuring the basic ophthalmological parameters (refraction, axial length, visual acuity), topographic keratometry, anterior segment optical coherence tomography, and ocular response analyzer were used for structural and functional assessment of the cornea and sclera.

Results: In MS there was a statistically significant increase in the radius of curvature and a decrease in corneal refraction in the central zone compared to the control group. There were no significant differences in central corneal thickness, but there was a significant decrease in the thickness of the sclera in the limbal zone compared to the control group. There were no statistically significant changes in corneal hysteresis and corneal resistance factor in MS.

Conclusion: This study confirmed the previously obtained data on the tendency of the optical power to reliably decrease in MS (flattening of the cornea). This symptom can be considered as a compensatory factor affecting clinical refraction, while the decrease in the thickness of the sclera - as the main reason for aaxial length elongation in MS. There were no clear patterns of dependence of the changes in the cornea and sclera analyzed in this study on the presence or absence of ectopia lentis. Changes in the lens, perhaps, should be regarded only as one of the potential components of the ocular symptom complex in MS.

马凡综合征(MS)是一种与 FBN1 基因突变有关的孤儿遗传性结缔组织疾病,其病理表现以多系统受累为特征。纤连蛋白-1 蛋白是眼睛巩膜和角膜不可或缺的组成部分,在 MS 中其结构被破坏:组成两组,在眼轴长度和年龄上具有可比性:主组--19 名确诊为多发性硬化症的患者(38 只眼),对照组--24 名患有不同程度近视的患者(48 只眼)。对多发性硬化症患者的结果进行了分析,具体取决于是否存在视网膜外翻。除了测量基本的眼科参数(屈光度、轴向长度、视力)外,还使用了角膜地形图测量法、前节光学相干断层扫描和眼部反应分析仪对角膜和巩膜的结构和功能进行评估:与对照组相比,多发性硬化症患者中央区角膜曲率半径明显增加,角膜屈光度明显下降。与对照组相比,中央区角膜厚度无明显差异,但边缘区巩膜厚度明显下降。多发性硬化症患者的角膜滞后和角膜阻力因子在统计学上没有明显变化:这项研究证实了之前获得的数据,即多发性硬化症(角膜变平)患者的视力有可靠的下降趋势。这一症状可被视为影响临床屈光的代偿因素,而巩膜厚度的减少则是多发性硬化症患者轴向长度延长的主要原因。本研究分析的角膜和巩膜的变化与是否存在晶状体异位没有明显的依赖关系。晶状体的变化也许只应被视为多发性硬化症眼部症状综合征的潜在组成部分之一。
{"title":"[Structural and functional features of the eye in Marfan syndrome. Report 1. Changes in the fibrous tunic of the eye].","authors":"K S Avetisov, E A Chizhonkova, S E Avetisov","doi":"10.17116/oftalma20241400115","DOIUrl":"10.17116/oftalma20241400115","url":null,"abstract":"<p><p>Marfan syndrome (MS) is an orphan hereditary connective tissue disease associated with a mutation in the <i>FBN1</i> gene, which pathological manifestations are characterized by polysystemic involvement. The fibrillin-1 protein is an integral component of the sclera and cornea of the eye, and in MS its structure is distrubed.</p><p><strong>Purpose: </strong>This study assesses potential structural and functional changes in the cornea and sclera of a patient with MS.</p><p><strong>Material and methods: </strong>Two groups were formed, comparable in the axial length of the eye and age: the main group - 19 patients (38 eyes) with a verified diagnosis of MS, and the control group - 24 patients (48 eyes) with myopia of varying degrees. The results obtained from MS patients were analyzed depending on the absence or presence of ectopia lentis. In addition to measuring the basic ophthalmological parameters (refraction, axial length, visual acuity), topographic keratometry, anterior segment optical coherence tomography, and ocular response analyzer were used for structural and functional assessment of the cornea and sclera.</p><p><strong>Results: </strong>In MS there was a statistically significant increase in the radius of curvature and a decrease in corneal refraction in the central zone compared to the control group. There were no significant differences in central corneal thickness, but there was a significant decrease in the thickness of the sclera in the limbal zone compared to the control group. There were no statistically significant changes in corneal hysteresis and corneal resistance factor in MS.</p><p><strong>Conclusion: </strong>This study confirmed the previously obtained data on the tendency of the optical power to reliably decrease in MS (flattening of the cornea). This symptom can be considered as a compensatory factor affecting clinical refraction, while the decrease in the thickness of the sclera - as the main reason for aaxial length elongation in MS. There were no clear patterns of dependence of the changes in the cornea and sclera analyzed in this study on the presence or absence of ectopia lentis. Changes in the lens, perhaps, should be regarded only as one of the potential components of the ocular symptom complex in MS.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rotational technique for emulsification of soft lens nucleus]. [软镜核乳化旋转技术]。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.17116/oftalma2024140022123
Yu N Yusef, S N Yusef, A S Vvedenskiy, M N Ivanov, L Alkharki, N D Fokina

Effective and atraumatic removal of a soft lens nucleus requires different surgical techniques compared to phacoemulsification of a dense nucleus.

Purpose: This study was conducted to develop a non-ultrasound technique for emulsification of a soft lens nucleus.

Material and methods: Fifty-seven patients (57 eyes) underwent surgery. In 23 cases, early or immature cataracts were detected, and in 34 cases, lens removal was performed for refractive purposes in high myopia and complex myopic astigmatism. Phacoemulsifier Centurion Vision System (Alcon Laboratories, Inc., USA) was used for the surgery. Aspiration of soft lens nucleus was done using a rotational technique. The following aspects were evaluated in the course of the surgery: the volume of the required irrigation solution, and the frequency needing to involve ultrasound for complete emulsification of the lens nucleus. Intraoperative and postoperative complications were also assessed.

Results: The surgery was uneventful in all cases. There were no violations of the integrity of capsulorhexis edge. The need for short pulses of minimal power ultrasound during the removal of the soft lens using this technique arose only in 11 (19.3%) cases. The effective ultrasound time was less than 1 second. The required volume of irrigation solution was 33.0 (24.0; 43.0) ml, which does not differ significantly from that in ultrasonic phacoemulsification.

Conclusions: The use of modern phacoemulsifiers providing a high vacuum level allows successful removal of a soft lens without using ultrasound, which prevents its negative impact on the ocular tissues. The use of adequate surgical techniques, including the optimal direction of rotation of the lens nucleus in the rotational technique, improves the efficiency of soft lens nucleus removal.

与致密晶状体核的超声乳化相比,有效、无创伤地摘除软晶状体核需要不同的手术技术。目的:本研究旨在开发一种非超声乳化软晶状体核的技术:57名患者(57只眼睛)接受了手术。其中 23 例为早期白内障或未成熟白内障,34 例为高度近视和复杂近视散光的屈光性晶状体摘除术。手术使用了超声乳化仪 Centurion Vision 系统(美国 Alcon 实验室公司)。采用旋转技术抽吸软晶状体核。手术过程中对以下方面进行了评估:所需灌洗液的量,以及超声波完全乳化晶状体核所需的频率。此外,还对术中和术后并发症进行了评估:所有病例的手术都很顺利。结果:所有病例的手术都很顺利,没有出现破坏晶状体边缘完整性的情况。使用该技术摘除软晶状体时,仅有 11 例(19.3%)病例需要使用短脉冲微功率超声波。有效超声时间不到 1 秒。所需的灌洗液量为 33.0 (24.0; 43.0) 毫升,与超声乳化术的灌洗液量没有明显差别:结论:使用具有高真空度的现代超声乳化器可以在不使用超声波的情况下成功摘除软性晶状体,从而避免了超声波对眼部组织的负面影响。使用适当的手术技术,包括旋转技术中晶状体核的最佳旋转方向,可提高软晶状体核摘除的效率。
{"title":"[Rotational technique for emulsification of soft lens nucleus].","authors":"Yu N Yusef, S N Yusef, A S Vvedenskiy, M N Ivanov, L Alkharki, N D Fokina","doi":"10.17116/oftalma2024140022123","DOIUrl":"https://doi.org/10.17116/oftalma2024140022123","url":null,"abstract":"<p><p>Effective and atraumatic removal of a soft lens nucleus requires different surgical techniques compared to phacoemulsification of a dense nucleus.</p><p><strong>Purpose: </strong>This study was conducted to develop a non-ultrasound technique for emulsification of a soft lens nucleus.</p><p><strong>Material and methods: </strong>Fifty-seven patients (57 eyes) underwent surgery. In 23 cases, early or immature cataracts were detected, and in 34 cases, lens removal was performed for refractive purposes in high myopia and complex myopic astigmatism. Phacoemulsifier Centurion Vision System (Alcon Laboratories, Inc., USA) was used for the surgery. Aspiration of soft lens nucleus was done using a rotational technique. The following aspects were evaluated in the course of the surgery: the volume of the required irrigation solution, and the frequency needing to involve ultrasound for complete emulsification of the lens nucleus. Intraoperative and postoperative complications were also assessed.</p><p><strong>Results: </strong>The surgery was uneventful in all cases. There were no violations of the integrity of capsulorhexis edge. The need for short pulses of minimal power ultrasound during the removal of the soft lens using this technique arose only in 11 (19.3%) cases. The effective ultrasound time was less than 1 second. The required volume of irrigation solution was 33.0 (24.0; 43.0) ml, which does not differ significantly from that in ultrasonic phacoemulsification.</p><p><strong>Conclusions: </strong>The use of modern phacoemulsifiers providing a high vacuum level allows successful removal of a soft lens without using ultrasound, which prevents its negative impact on the ocular tissues. The use of adequate surgical techniques, including the optimal direction of rotation of the lens nucleus in the rotational technique, improves the efficiency of soft lens nucleus removal.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 2. Vyp. 2","pages":"123-128"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vestnik oftalmologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1